Physician profile

Guido A Laporta

Foot & Ankle Surgery · Dunmore, PA

NPI 1205892684

$624,851.42

in general payments reported to CMS, 2019-2025

43 companies · $43K in 2025

The $43K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$108,220.50
Travel and Lodging$22,552.01
Food and Beverage$3,856.46
Royalty Or License$3,409.84

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $433,279.88 2019-2025 Hoffmann, Salvation, T2
Zimmer Biomet Holdings, INC. $136,700.80 2019-2023 Accuport Cannula
Orthofix Medical, INC. $21,131.37 2020-2025 Truelok, Physio-Stim
Medical Device Business Services, INC. $11,776.31 2019-2022
Treace Medical Concepts, INC. $5,199.15 2019-2025
Synthes USA Products LLC $4,340.52 2019
Paragon 28, INC. $3,612.17 2019-2024 Portfolio, Monkey Rings, Precision Mis Bunion
Fh Orthopedics, INC. $2,727.85 2019
Prodigy Surgical Distribution, INC. $2,502.29 2019-2023
Smith+Nephew, INC. $733.66 2019-2025 Grafix Pl, Oasis, Stravix Pl
Integra Lifesciences Corporation $547.35 2019-2025 Integra, Primatrix, Integra Dermal Regeneration Template
Bone Support INC. $376.70 2022
Nuvasive Specialized Orthopedics, INC. $163.94 2022
Depuy Synthes Sales INC. $134.46 2019-2024
Abbvie INC. $127.27 2019-2025
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Advanced Oxygen Therapy INC. $126.92 2022-2023 Topical Oxygen Chamber For Extremities
Terumo Bct, INC. $124.70 2020-2021
Organogenesis INC. $119.93 2020-2025 Cygnus Dual
Novastep INC. $119.60 2021
Sanara Medtech INC. $102.66 2022
Misonix INC $86.39 2019-2020
Kci USA, INC. $82.07 2020-2021
Globus Medical, INC. $75.29 2023 Retrieve
Paratek Pharmaceuticals, INC. $72.51 2024-2025 Nuzyra
Solventum Corporation $66.54 2024-2025 Prevena, Activ.A.C., Abthera
Melinta Therapeutics, LLC $56.14 2019
Wright Medical Technology, INC. $53.48 2019
Alfasigma USA, INC. $51.57 2021
Mimedx Group, INC. $45.15 2025
Arthrosurface Incorporated $40.41 2019
Cerapedics INC. $38.39 2021-2022
Allergan, INC. $34.16 2019-2020
Bioventus LLC $25.18 2024 Exogen Ultrasound Bone Healing System
Tei Medical INC. $25.01 2019
Exactech, INC. $23.79 2019
Abbott Laboratories $22.43 2025 Proclaim
Linvatec Corporation $18.17 2019
Fidia Pharma USA INC. $17.93 2021
Novus Surgical Solutions LLC $17.69 2022
Baxter Healthcare $14.70 2021
Merck Sharp & Dohme LLC $13.10 2019
Tenex Health INC. $12.68 2020
Djo, LLC $11.11 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Guido A Laporta

$624,851.42

in general payments reported 2019-2025

Years
2019-2025
Top company
Stryker Corporation
Context
The $43K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/236428/guido-a-laporta

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.